Posted On: 10/23/2014 7:15:25 AM
Post# of 30035
I see Jason Napodano is now pumping another company developing an AD test.
"The company is also developing an AD diagnostic test with early results showing sensitivity (correctly diagnosing AD) = 97% and specificity (correctly identifying individuals without AD) = 96%."
http://seekingalpha.com/article/2575735-neuro...-mechanism
"The company is also developing an AD diagnostic test with early results showing sensitivity (correctly diagnosing AD) = 97% and specificity (correctly identifying individuals without AD) = 96%."
http://seekingalpha.com/article/2575735-neuro...-mechanism
(0)
(0)Scroll down for more posts ▼
